Neuer Wirkstoff bei Psoriasis-Arthritis für die Basistherapie • MedWiss.Online

Original Titel:
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a…